Lawrence M. Alleva - 03 Jul 2023 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ Lawrence Michael Alleva
Issuer symbol
ADAP
Transactions as of
03 Jul 2023
Net transactions value
$0
Form type
4
Filing time
03 Jul 2023, 17:02:08 UTC
Previous filing
05 Jul 2023
Next filing
04 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +1,077,756 $0.000000 1,077,756 03 Jul 2023 Ordinary Shares 1,077,756 $0.1600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.12 based on an exchange rate of $U.S. 1.270841 to GBP1.00. The actual exercise price will be the pounds sterling amount.